Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Refractory (Phase 1)
Asthma (Phase 1)
Astrocytoma (Phase 2)
Bone Marrow Cells (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Merkel Cell (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Conjunctival Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Hemorrhagic Fever, Ebola (Phase 1)
Hepatitis B, Chronic (Phase 4)
HIV Infections (Phase 2)
Inflammatory Breast Neoplasms (Early Phase 1)
Influenza A Virus, H3N2 Subtype (Phase 2)
Influenza, Human (Phase 1)
Kidney Neoplasms (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Liver Neoplasms (Phase 1/Phase 2)
Lung Diseases (Phase 1)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1/Phase 2)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Cutaneous (Phase 1/Phase 2)
Medulloblastoma (Phase 1/Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 1/Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Myeloproliferative Disorders (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasm Recurrence, Local (Phase 1)
Neoplasms (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 1/Phase 2)
Neurofibroma (Phase 2)
Oligodendroglioma (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 1)
Sarcoma (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Smallpox (Phase 1)
Smoldering Multiple Myeloma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Testicular Neoplasms (Phase 1/Phase 2)
Thrombocythemia, Essential (Phase 1)
Triple Negative Breast Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue